We are live on ! Find out more
HITK

HI-TECH PHARMACAL INC
HITK

Delisted

HITK was delisted on the 16th of April, 2014.

Back to rankings

1 hedge funds and large institutions have $43 invested in HI-TECH PHARMACAL INC in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

HITK Hedge Fund Activity: Q4 2022 in Review

1 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in HI-TECH PHARMACAL INC (HITK) for Q4 2022, worth a combined $43.

Fund positioning in HITK was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held HI-TECH PHARMACAL INC (HITK) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $43 of HI-TECH PHARMACAL INC stock for Q4 2022.
  • 0 funds opened new HI-TECH PHARMACAL INC positions in Q4 2022 and 0 closed out.

Based on aggregated 13F filings for Q4 2022.